{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:33:58Z","timestamp":1787502838484,"version":"build-2736575974"},"reference-count":83,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Since the first animal model of valproic acid (VPA) induced autistic-like behavior, many genetic and non-genetic experimental animal models for Autism Spectrum Disorder (ASD) have been described. The more common non-genetic animal models induce ASD in rats and mice by infection\/inflammation or the prenatal or early postnatal administration of VPA. Through the establishment of these models, attempts have been made to ameliorate or even prevent ASD-like symptoms. Some of the genetic models have been successfully treated by genetic manipulations or the manipulation of neurotransmission. Different antioxidants have been used (i.e., astaxanthin, green tea, piperine) to reduce brain oxidative stress in VPA-induced ASD models. Agents affecting brain neurotransmitters (donepezil, agmatine, agomelatine, memantine, oxytocin) also successfully reduced ASD-like symptoms. However, complete prevention of the development of symptoms was achieved only rarely. In our recent study, we treated mouse offspring exposed on postnatal day four to VPA with S-adenosine methionine (SAM) for three days, and prevented ASD-like behavior, brain oxidative stress, and the changes in gene expression induced by VPA. In this review, we describe, in addition to our data, the existing literature on the prevention\/amelioration of ASD-like symptoms. We also discuss the possible mechanisms underlying some of these phenomena. Finally, we describe some of the clinical trials in children with ASD that were carried out as a result of data from animal studies, especially those with polyunsaturated fatty acids (PUFAs).<\/jats:p>","DOI":"10.3390\/ijms20051074","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T05:45:36Z","timestamp":1551678336000},"page":"1074","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Prevention or Amelioration of Autism-Like Symptoms in Animal Models: Will it Bring Us Closer to Treating Human ASD?"],"prefix":"10.3390","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7268-3512","authenticated-orcid":false,"given":"Asher","family":"Ornoy","sequence":"first","affiliation":[{"name":"Laboratory of Teratology, Department of Medical Neurobiology, Hebrew University Hadassah Medical School, Jerusalem 9112001, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza","family":"Weinstein-Fudim","sequence":"additional","affiliation":[{"name":"Laboratory of Teratology, Department of Medical Neurobiology, Hebrew University Hadassah Medical School, Jerusalem 9112001, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zivanit","family":"Ergaz","sequence":"additional","affiliation":[{"name":"Laboratory of Teratology, Department of Medical Neurobiology, Hebrew University Hadassah Medical School, Jerusalem 9112001, Israel"},{"name":"Neonatology Department, Hadassah Hebrew University Medical Center, Jerusalem 9112001, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,3,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6706a1","article-title":"Prevalence of Autism Spectrum Disorder among Children Aged 8 Years\u2014Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014","volume":"67","author":"Baio","year":"2018","journal-title":"MMWR Surveill. Summ."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e20174161","DOI":"10.1542\/peds.2017-4161","article-title":"The Prevalence of Parent-Reported Autism Spectrum Disorder Among US Children","volume":"142","author":"Kogan","year":"2018","journal-title":"Pediatrics"},{"key":"ref_3","unstructured":"(2013). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association Publishing. [5th ed.]."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.reprotox.2016.04.024","article-title":"Genetic and non-genetic animal models for autism spectrum disorders (ASD)","volume":"64","author":"Ergaz","year":"2016","journal-title":"Reprod. Toxicol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neuron.2012.07.022","article-title":"Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice","volume":"76","author":"Bhattacharya","year":"2012","journal-title":"Neuron"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/hmg\/dds406","article-title":"Female Mecp2(+\/\u2212) mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies","volume":"22","author":"Samaco","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neubiorev.2016.12.037","article-title":"The BTBR mouse model of idiopathic autism\u2014Current view on mechanisms","volume":"76","author":"Meyza","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/npp.2014.291","article-title":"Early social enrichment rescues adult behavioral and brain abnormalities in a mouse model of fragile X syndrome","volume":"40","author":"Oddi","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.psyneuen.2014.07.002","article-title":"Dietary supplementation of omega-3 fatty acids rescues fragile X phenotypes in Fmr1-Ko mice","volume":"49","author":"Pietropaolo","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5607\/en.2015.24.4.312","article-title":"Is Oxytocin Application for Autism Spectrum Disorder Evidence-Based?","volume":"24","author":"Lee","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-3-319-52498-6_8","article-title":"The Role of the Oxytocin\/Arginine Vasopressin System in Animal Models of Autism Spectrum Disorder","volume":"224","author":"Zhang","year":"2017","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/7854_2017_15","article-title":"Oxytocin and Animal Models for Autism Spectrum Disorder","volume":"35","author":"Wagner","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neuropharm.2013.04.038","article-title":"Prosocial effects of oxytocin in two mouse models of autism spectrum disorders","volume":"72","author":"Teng","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuropharm.2015.12.025","article-title":"Reversal of social deficits by subchronic oxytocin in two autism mouse models","volume":"105","author":"Teng","year":"2016","journal-title":"Neuropharmacology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1523\/JNEUROSCI.2010-17.2017","article-title":"Insulin-Like Growth Factor II Targets the mTOR Pathway to Reverse Autism-Like Phenotypes in Mice","volume":"38","author":"Steinmetz","year":"2018","journal-title":"J. Neurosci."},{"key":"ref_17","unstructured":"Avraham, Y., Berry, E.M., Donskoy, M., Ahmad, W.A., Vorobiev, L., Albeck, A., and Mankuta, D. (2017). Beta-carotene as a novel therapy for the treatment of \u201cAutistic like behavior\u201d in animal models of Autism. Behav. Brain Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"131ra151","DOI":"10.1126\/scitranslmed.3003501","article-title":"Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism","volume":"4","author":"Silverman","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuropharm.2017.08.029","article-title":"Allosteric modulation of nicotinic and GABAA receptor subtypes differentially modify autism-like behaviors in the BTBR mouse model","volume":"126","author":"Yoshimura","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2016.05.019","article-title":"C57BL\/6J bone marrow transplant increases sociability in BTBR T(+) Itpr3(tf)\/J mice","volume":"59","author":"Schwartzer","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ornoy, A., Weinstein-Fudim, L., Tfilin, M., Ergaz, Z., Yanai, J., Szyf, M., and Turgeman, G. (2018). S-adenosyl methionine prevents ASD like behaviors triggered by early postnatal valproic acid exposure in very young mice. Neurotoxicol. Teratol.","DOI":"10.1016\/j.ntt.2018.01.005"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.reprotox.2015.05.007","article-title":"Prenatal factors associated with autism spectrum disorder (ASD)","volume":"56","author":"Ornoy","year":"2015","journal-title":"Reprod. Toxicol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bbi.2010.03.005","article-title":"Effects of prenatal infection on brain development and behavior: A review of findings from animal models","volume":"24","author":"Boksa","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1016\/j.ajpath.2011.02.042","article-title":"Placental TNF-alpha signaling in illness-induced complications of pregnancy","volume":"178","author":"Carpentier","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.braindev.2014.03.007","article-title":"Maternal viral infection during pregnancy impairs development of fetal serotonergic neurons","volume":"37","author":"Ohkawara","year":"2015","journal-title":"Brain Dev."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Xuan, I.C., and Hampson, D.R. (2014). Gender-dependent effects of maternal immune activation on the behavior of mouse offspring. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0104433"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbr.2008.12.016","article-title":"Immune involvement in schizophrenia and autism: Etiology, pathology and animal models","volume":"204","author":"Patterson","year":"2009","journal-title":"Behav. Brain Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbr.2006.06.013","article-title":"Abnormal social behaviors in young and adult rats neonatally infected with Borna disease virus","volume":"176","author":"Lancaster","year":"2007","journal-title":"Behav. Brain Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kirsten, T.B., Casarin, R.C., Bernardi, M.M., and Felicio, L.F. (2018). Pioglitazone abolishes autistic-like behaviors via the IL-6 pathway. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0197060"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1126\/science.aad0314","article-title":"The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring","volume":"351","author":"Choi","year":"2016","journal-title":"Science"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13229-017-0125-0","article-title":"Vitamin D treatment during pregnancy prevents autism-related phenotypes in a mouse model of maternal immune activation","volume":"8","author":"Vuillermot","year":"2017","journal-title":"Mol. Autism"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1469-8749.1994.tb11858.x","article-title":"Fetal valproate syndrome: Clinical and neuro-developmental features in two sibling pairs","volume":"36","author":"Christianson","year":"1994","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1469-8749.2001.tb00188.x","article-title":"Fetal valproate syndrome and autism: Additional evidence of an association","volume":"43","author":"Williams","year":"2001","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0012162205001076","article-title":"Characteristics of fetal anticonvulsant syndrome associated autistic disorder","volume":"47","author":"Rasalam","year":"2005","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.wnl.0000339399.64213.1a","article-title":"Autism spectrum disorders following in utero exposure to antiepileptic drugs","volume":"71","author":"Bromley","year":"2008","journal-title":"Neurology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/jmg.37.7.489","article-title":"A clinical study of 57 children with fetal anticonvulsant syndromes","volume":"37","author":"Moore","year":"2000","journal-title":"J. Med. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: Animal model of autism","volume":"30","author":"Schneider","year":"2005","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s10803-006-0117-y","article-title":"A new neurobehavioral model of autism in mice: Pre- and postnatal exposure to sodium valproate","volume":"36","author":"Wagner","year":"2006","journal-title":"J. Autism Dev. Disord."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0890-6238(97)80001-U","article-title":"Linking etiologies in humans and animal models: Studies of autism","volume":"11","author":"Rodier","year":"1997","journal-title":"Reprod. Toxicol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0892-0362(99)00083-5","article-title":"Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism","volume":"22","author":"Ingram","year":"2000","journal-title":"Neurotoxicol. Teratol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brainres.2011.06.063","article-title":"Amelioration of behavioral aberrations and oxidative markers by green tea extract in valproate induced autism in animals","volume":"1410","author":"Banji","year":"2011","journal-title":"Brain Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbr.2015.02.041","article-title":"Astaxanthin improves behavioral disorder and oxidative stress in prenatal valproic acid-induced mice model of autism","volume":"286","author":"Rahman","year":"2015","journal-title":"Behav. Brain Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbr.2014.04.045","article-title":"Ameliorating effect of piperine on behavioral abnormalities and oxidative markers in sodium valproate induced autism in BALB\/C mice","volume":"270","author":"Pragnya","year":"2014","journal-title":"Behav. Brain Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s13105-016-0532-2","article-title":"Comparative efficacy of alpha-linolenic acid and gamma-linolenic acid to attenuate valproic acid-induced autism-like features","volume":"73","author":"Yadav","year":"2017","journal-title":"J. Physiol. Biochem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuint.2015.10.007","article-title":"Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder","volume":"91","author":"Kumar","year":"2015","journal-title":"Neurochem. Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainres.2015.10.052","article-title":"Minocycline ameliorates prenatal valproic acid induced autistic behaviour, biochemistry and blood brain barrier impairments in rats","volume":"1630","author":"Kumar","year":"2016","journal-title":"Brain Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainresbull.2016.03.013","article-title":"Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats","volume":"124","author":"Kumar","year":"2016","journal-title":"Brain Res. Bull."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neuropharm.2016.09.014","article-title":"Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism","volume":"113","author":"Kim","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Kim, J.W., Seung, H., Kwon, K.J., Ko, M.J., Lee, E.J., Oh, H.A., Choi, C.S., Kim, K.C., Gonzales, E.L., and You, J.S. (2014). Subchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behavior in valproic acid-induced animal model of autism. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0104927"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbr.2015.04.022","article-title":"Reduced prefrontal dopaminergic activity in valproic acid-treated mouse autism model","volume":"289","author":"Hara","year":"2015","journal-title":"Behav. Brain Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3389\/fncel.2018.00355","article-title":"Neonatal Oxytocin Treatment Ameliorates Autistic-Like Behaviors and Oxytocin Deficiency in Valproic Acid-Induced Rat Model of Autism","volume":"12","author":"Dai","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bbr.2016.10.004","article-title":"Human adipose-derived stem cells ameliorate repetitive behavior, social deficit and anxiety in a VPA-induced autism mouse model","volume":"317","author":"Ha","year":"2017","journal-title":"Behav. Brain Res."},{"key":"ref_54","first-page":"791","article-title":"Gender differences in the expression of nervous system genes in a mouse model of valproic acid-induced autism-like behavior is corrected by S-adenosyl methionine","volume":"11","author":"Ornoy","year":"2018","journal-title":"Birth Defects Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jamaneurol.2017.3897","article-title":"Association of Folic Acid Supplementation During Pregnancy with the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero","volume":"75","author":"Bjork","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/aur.1596","article-title":"Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism","volume":"9","author":"Hara","year":"2016","journal-title":"Autism Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.yhbeh.2017.09.013","article-title":"Oxytocin attenuates deficits in social interaction but not recognition memory in a prenatal valproic acid-induced mouse model of autism","volume":"96","author":"Hara","year":"2017","journal-title":"Horm. Behav."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Segal-Gavish, H., Karvat, G., Barak, N., Barzilay, R., Ganz, J., Edry, L., Aharony, I., Offen, D., and Kimchi, T. (2015). Mesenchymal Stem Cell Transplantation Promotes Neurogenesis and Ameliorates Autism Related Behaviors in BTBR Mice. Autism Res. Off. J. Int. Soc. Autism Res.","DOI":"10.1002\/aur.1530"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Seibenhener, M.L., and Wooten, M.C. (2015). Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice. J. Vis. Exp., e52434.","DOI":"10.3791\/52434-v"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/neu.1995.12.1","article-title":"A sensitive and reliable locomotor rating scale for open field testing in rats","volume":"12","author":"Basso","year":"1995","journal-title":"J. Neurotrauma"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neures.2017.04.012","article-title":"Early deprivation increases high-leaning behavior, a novel anxiety-like behavior, in the open field test in rats","volume":"123","author":"Kuniishi","year":"2017","journal-title":"Neurosci. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/mrdd.20039","article-title":"Designing mouse behavioral tasks relevant to autistic-like behaviors","volume":"10","author":"Crawley","year":"2004","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Kaidanovich-Beilin, O., Lipina, T., Vukobradovic, I., Roder, J., and Woodgett, J.R. (2011). Assessment of social interaction behaviors. J. Vis. Exp., 2473.","DOI":"10.3791\/2473-v"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Komada, M., Takao, K., and Miyakawa, T. (2008). Elevated plus maze for mice. J. Vis. Exp., 1088.","DOI":"10.3791\/1088-v"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nrn2851","article-title":"Behavioural phenotyping assays for mouse models of autism","volume":"11","author":"Silverman","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nprot.2006.2","article-title":"T-maze alternation in the rodent","volume":"1","author":"Deacon","year":"2006","journal-title":"Nat. Protoc."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbr.2006.07.030","article-title":"Mouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strains","volume":"176","author":"Moy","year":"2007","journal-title":"Behav. Brain Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s12031-014-0457-6","article-title":"Mesenchymal stem cells can prevent alterations in behavior and neurogenesis induced by Ass25\u201335 administration","volume":"55","author":"Hamisha","year":"2015","journal-title":"J. Mol. Neurosci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jneumeth.2013.08.019","article-title":"Water T-maze: A useful assay for determination of repetitive behaviors in mice","volume":"220","author":"Guariglia","year":"2013","journal-title":"J. Neurosci. Methods"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0006-8993(92)91352-F","article-title":"A two-trial memory task with automated recording: Study in young and aged rats","volume":"588","author":"Dellu","year":"1992","journal-title":"Brain Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/nprot.2013.155","article-title":"Object recognition test in mice","volume":"8","author":"Leger","year":"2013","journal-title":"Nat. Protoc."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","article-title":"The novel object recognition memory: Neurobiology, test procedure, and its modifications","volume":"13","author":"Antunes","year":"2012","journal-title":"Cogn. Process."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2478\/intox-2013-0020","article-title":"Determination of motor activity and anxiety-related behaviour in rodents: Methodological aspects and role of nitric oxide","volume":"6","author":"Sestakova","year":"2013","journal-title":"Interdiscip. Toxicol."},{"key":"ref_74","unstructured":"Buccafusco, J.J. (2009). Anxiety-Related Behaviors in Mice. Methods of Behavior Analysis in Neuroscience, CRC Press\/Taylor & Francis. [2nd ed.]."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/neu.1994.11.187","article-title":"The rotarod test: An evaluation of its effectiveness in assessing motor deficits following traumatic brain injury","volume":"11","author":"Hamm","year":"1994","journal-title":"J. Neurotrauma"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Angoa-Perez, M., Kane, M.J., Briggs, D.I., Francescutti, D.M., and Kuhn, D.M. (2013). Marble burying and nestlet shredding as tests of repetitive, compulsive-like behaviors in mice. J. Vis. Exp., 50978.","DOI":"10.3791\/50978-v"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Morgese, M.G., and Trabace, L. (2016). Maternal Malnutrition in the Etiopathogenesis of Psychiatric Diseases: Role of Polyunsaturated Fatty Acids. Brain Sci., 6.","DOI":"10.3390\/brainsci6030024"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Agostoni, C., Nobile, M., Ciappolino, V., Delvecchio, G., Tesei, A., Turolo, S., Crippa, A., Mazzocchi, A., Altamura, C.A., and Brambilla, P. (2017). The Role of Omega-3 Fatty Acids in Developmental Psychopathology: A Systematic Review on Early Psychosis, Autism, and ADHD. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122608"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/JCP.0b013e3182485791","article-title":"Effects of large doses of arachidonic acid added to docosahexaenoic acid on social impairment in individuals with autism spectrum disorders: A double-blind, placebo-controlled, randomized trial","volume":"32","author":"Yui","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jaac.2014.01.018","article-title":"Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism","volume":"53","author":"Bent","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/MPG.0000000000000260","article-title":"Dietary docosahexaenoic acid supplementation in children with autism","volume":"58","author":"Voigt","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3945\/jn.116.242354","article-title":"omega-3 Fatty Acid Supplementation Does Not Affect Autism Spectrum Disorder in Children: A Systematic Review and Meta-Analysis","volume":"147","author":"Horvath","year":"2017","journal-title":"J. Nutr."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.2147\/NDT.S147305","article-title":"Supplementation of omega 3 fatty acids may improve hyperactivity, lethargy, and stereotypy in children with autism spectrum disorders: A meta-analysis of randomized controlled trials","volume":"13","author":"Cheng","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/5\/1074\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:35:40Z","timestamp":1760186140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/5\/1074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":83,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["ijms20051074"],"URL":"https:\/\/doi.org\/10.3390\/ijms20051074","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,1]]}}}